The historical rank and industry rank for Zenlabs Ethica's OCF Margin % or its related term are showing as below:
BOM:530697'
s OCF Margin % Range Over the Past 10 Years
Min: -15.47 Med: 0.63 Max: 8.66
Current: 8.66
During the past 13 years, the highest OCF Margin % of Zenlabs Ethica was 8.66%. The lowest was -15.47%. And the median was 0.63%.
BOM:530697's OCF Margin % is ranked better than 82.76% of 116
companies
in the Medical Distribution industry
Industry Median: 2.165
vs BOM:530697: 8.66
Zenlabs Ethica OCF Margin % Related Terms
Zenlabs Ethica OCF Margin % Historical Data
* Premium members only.
The historical data trend for Zenlabs Ethica's OCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BOM:530697 vs MCK, CAH, COR: OCF Margin % Comparison
For the Medical Distribution subindustry, Zenlabs Ethica's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Zenlabs Ethica OCF Margin % vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Zenlabs Ethica's OCF Margin % distribution charts can be found below:
* The bar in red indicates where Zenlabs Ethica's OCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Zenlabs Ethica (BOM:530697) has a OCF Margin % of 0.00% as of Mar. 2026. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Zenlabs Ethica and its competitors. According to the industry distribution chart, Zenlabs Ethica ranks #20 out of 116 companies in the Medical Distribution industry, placing it in the top 17.2%.
Is Zenlabs Ethica's OCF Margin % too high?
Zenlabs Ethica's current OCF Margin % is 0.00%. Based on the distribution chart, Zenlabs Ethica ranks #20 out of 116 companies in the Medical Distribution industry, which is in the top quartile — a strong position relative to peers. Overall, Zenlabs Ethica has a GF Score™ of 53/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Zenlabs Ethica's OCF Margin % compare to MCK and CAH?
According to the Medical Distribution industry distribution chart, Zenlabs Ethica ranks #20 out of 116 companies for OCF Margin %. This places Zenlabs Ethica in the top 17% of its industry — outperforming the majority of peers. The industry median OCF Margin % is 2.17. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Medical Distribution company?
The median OCF Margin % among Medical Distribution companies is 2.17, based on 116 companies in the industry. Companies in the top quartile (top 25%) have a OCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Zenlabs Ethica and its competitors. For the Medical Distribution industry, the median OCF Margin % is 2.17 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Zenlabs Ethica's current OCF Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Zenlabs Ethica stock overvalued right now?
Based on GuruFocus' analysis, Zenlabs Ethica (BOM:530697) is currently considered Modestly Overvalued. The stock's GF Value™ is ₹29.36, compared to a current price of ₹34.20 — trading 16.5% above its estimated fair value. The current OCF Margin % is 0.00%. Zenlabs Ethica's overall GF Score™ is 53/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Zenlabs Ethica (BOM:530697), the current OCF Margin % is 0.00% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Zenlabs Ethica (BOM:530697) Overvalued in 2026?
Based on GuruFocus' analysis, Zenlabs Ethica stock appears to be overvalued.
The current stock price of ₹34.20 is trading 16.5% above its estimated GF Value™ of ₹29.36.
GuruFocus considers Zenlabs Ethica to be Modestly Overvalued.
Key valuation signals for BOM:530697:
OCF Margin %: 0.00%
GF Value™: ₹29.36 vs. price of ₹34.20 (16.5% above fair value)
No single metric tells the full story. See the BOM:530697 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Zenlabs Ethica Ltd is a pharmaceutical company engaged in the trading of pharmaceutical formulations. It manufactures and markets drugs which include Gastrointestinal disorders, anti-diabetics, anti-hypertensive drugs, anti-infective, soaps, and anti-Bacterial drugs, nutraceuticals, and others. In addition, The company offers more than 600 products across therapeutic segments.
53GF Score
Get the complete analysis for BOM:530697
OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:530697 has been successfully added to your 
